These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21925445)

  • 21. Osteoporosis knowledge in patients with a first fragility fracture in Puerto Rico.
    Díaz-Correa LM; Ramírez-García LM; Castro-Santana LE; Vilá LM
    Bol Asoc Med P R; 2014; 106(1):6-10. PubMed ID: 24791357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low rates of treatment in postmenopausal women with a history of low trauma fractures: results of audit in a Fracture Liaison Service.
    Premaor MO; Pilbrow L; Tonkin C; Adams M; Parker RA; Compston J
    QJM; 2010 Jan; 103(1):33-40. PubMed ID: 19864348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update of current therapeutic options for the treatment of postmenopausal osteoporosis.
    Epstein S
    Clin Ther; 2006 Feb; 28(2):151-73. PubMed ID: 16678639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strontium: new drug. Postmenopausal osteoporosis: too many unknowns.
    Prescrire Int; 2005 Dec; 14(80):207-11. PubMed ID: 16397977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adherence to oral bisphosphonates: 30 more minutes in dosing instructions matter.
    Vytrisalova M; Touskova T; Ladova K; Fuksa L; Palicka V; Matoulkova P; Horak P; Stepan J
    Climacteric; 2015; 18(4):608-16. PubMed ID: 25495333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and causes for failure of treatment of women with proven osteoporosis.
    Zafran N; Liss Z; Peled R; Sherf M; Reuveni H
    Osteoporos Int; 2005 Nov; 16(11):1375-83. PubMed ID: 15806322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Non-hormonal treatments of postmenopausal osteoporosis].
    Malaise O; Neuprez A; Reginster JY
    Gynecol Obstet Fertil; 2008; 36(7-8):815-22. PubMed ID: 18653373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of a national multicentric study on compliance to treatment with various disphosphonate formulations in patients with postmenopausal osteoporosis.
    Vinicola V; Giampà E; Di Bonito M; Ferretti V; Nuvoli G; Paoletti F; Piazzini M; Ranieri M; Tuveri MA
    Minerva Endocrinol; 2015 Sep; 40(3):187-93. PubMed ID: 26205647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis.
    Penning-van Beest FJ; Goettsch WG; Erkens JA; Herings RM
    Clin Ther; 2006 Feb; 28(2):236-42. PubMed ID: 16678644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A community-based clinical trial of Intra-Venous zOledRonic acid once Yearly in comparison to oral bisphosphonates in postmenopausal women with osteoporosis: the IVORY trial Methodological considerations.
    Brown JP; Adachi JD; Kendler DL; Rigal R; Deutsch G; Leclerc JM
    Contemp Clin Trials; 2011 Sep; 32(5):741-6. PubMed ID: 21628001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No difference between strontium ranelate (SR) and calcium/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trial.
    Anastasilakis AD; Goulis DG; Polyzos SA; Gerou S; Ballaouri I; Efstathiadou Z; Kita M; Avramidis A
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):522-6. PubMed ID: 18625000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
    Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
    J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation: a controlled longitudinal study.
    Benetti A; Crosignani A; Varenna M; Giussani CS; Allocca M; Zuin M; Podda M; Battezzati PM
    J Clin Gastroenterol; 2008 Mar; 42(3):306-11. PubMed ID: 18223492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of vitamin D in the treatment of osteoporosis in the elderly].
    Pfeifer M; Minne HW
    Med Klin (Munich); 2006 Jun; 101 Suppl 1():15-9. PubMed ID: 16826364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How can osteoporosis patients benefit more from their therapy? Adherence issues with bisphosphonate therapy.
    Gold DT; Alexander IM; Ettinger MP
    Ann Pharmacother; 2006 Jun; 40(6):1143-50. PubMed ID: 16735667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drugs for postmenopausal osteoporosis.
    Treat Guidel Med Lett; 2011 Nov; 9(111):67-74. PubMed ID: 22033166
    [No Abstract]   [Full Text] [Related]  

  • 38. Adherence and persistence in patients with severe osteoporosis treated with teriparatide.
    Ziller V; Zimmermann SP; Kalder M; Ziller M; Seker-Pektas B; Hellmeyer L; Hadji P
    Curr Med Res Opin; 2010 Mar; 26(3):675-81. PubMed ID: 20078188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapeutic compliance in patients with arterial hypertension and type 2 diabetes mellitus].
    Gutiérrez-Angulo ML; Lopetegi-Uranga P; Sánchez-Martín I; Garaigordobil-Landazabal M
    Rev Calid Asist; 2012; 27(2):72-7. PubMed ID: 22138203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-reported calcium use in a cohort of postmenopausal women receiving osteoporosis therapy: results from POSSIBLE US™.
    Barrett-Connor E; Wade SW; Downs RW; Ganiats T; Hochberg M; Recker RR; Stolshek BS
    Osteoporos Int; 2015 Aug; 26(8):2175-84. PubMed ID: 25876880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.